Evidence map›Paper›PMID 21179236›Full record

ArticleMolecular vision2010

Analysis of candidate genes for macular telangiectasia type 2.

Nancy L Parmalee, Carl Schubert, Joanna E Merriam, Kaija Allikmets, Alan C Bird, Mark C Gillies, Tunde Peto, Maria Figueroa, Martin Friedlander, Marcus Fruttiger and 6 more

Open access · greenAbstract read
In one paragraph

Article in Molecular vision, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 29 citations in OpenAlex.

  1. Trial
  2. Review
  3. Genetic Background of Macular Telangiectasia Type 2.International journal of molecular sciences · 2025
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Observational
  11. Article
  12. A new CRB1 rat mutation links Müller glial cells to retinal telangiectasia.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2015
    Article
  13. Macular telangiectasia type 2.Progress in retinal and eye research · 2013
    Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Nancy L ParmaleeDepartment of Ophthalmology, Columbia University, New York, NY 10032, USA.
Carl Schubert
Joanna E Merriam
Kaija Allikmets
Alan C Bird
Mark C Gillies
Tunde Peto
Maria Figueroa
Martin Friedlander
Marcus Fruttiger
John Greenwood
Stephen E Moss
Lois E H Smith
Carmel Toomes
Chris F Inglehearn
Rando Allikmets
Columbia University · US

Funding

Vision Sciences Training GrantT32EY013933 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Carol A. Mason, CAROL M TROY · 2001 to 2026
$5.3M
NEI NIH HHS T32 EY013933
6 · The paper itself

Abstract

purposeTo find the gene(s) responsible for macular telangiectasia type 2 (MacTel) by a candidate-gene screening approach.

methodsCandidate genes were selected based on the following criteria: those known to cause or be associated with diseases with phenotypes similar to MacTel, genes with known function in the retinal vasculature or macular pigment transport, genes that emerged from expression microarray data from mouse models designed to mimic MacTel phenotype characteristics, and genes expressed in the retina that are also related to diabetes or hypertension, which have increased prevalence in MacTel patients. Probands from eight families with at least two affected individuals were screened by direct sequencing of 27 candidate genes. Identified nonsynonymous variants were analyzed to determine whether they co-segregate with the disease in families. Allele frequencies were determined by TaqMan analysis of the large MacTel and control cohorts.

resultsWe identified 23 nonsynonymous variants in 27 candidate genes in at least one proband. Of these, eight were known single nucleotide polymorphisms (SNPs) with allele frequencies of >0.05; these variants were excluded from further analyses. Three previously unidentified missense variants, three missense variants with reported disease association, and five rare variants were analyzed for segregation and/or allele frequencies. No variant fulfilled the criteria of being causal for MacTel. A missense mutation, p.Pro33Ser in frizzled homolog (Drosophila) 4 (FZD4), previously suggested as a disease-causing variant in familial exudative vitreoretinopathy, was determined to be a rare benign polymorphism.

conclusionsWe have ruled out the exons and flanking intronic regions in 27 candidate genes as harboring causal mutations for MacTel.

Indexed as

AdultAgedAged, 80 and overAnimalsBiological TransportChromosome SegregationDNA Mutational AnalysisFemaleGene Expression ProfilingGenetic LinkageHumansMacula LuteaMaleMiceMiddle AgedNeovascularization, PathologicRetinal Pigments

Identifiers

PMID21179236
PMCPMC3002960
OpenAlexW2141847559

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.